Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adhesion G protein-coupled receptor G3 (ADGRG3, also known as GPR97) is a member of the adhesion GPCR family characterized by a long extracellular N-terminus and a GPCR-Autoproteolysis INducing (GAIN) domain linking it to the seven-transmembrane region. It is primarily expressed in granulocytes (neutrophils, eosinophils, basophils), monocytes, endothelial cells, and certain lymphocytes. The receptor is involved in innate immune signaling, controlling cell adhesion, migration, and antimicrobial activity. Upon binding glucocorticoids, GPR97 activates G protein-dependent signaling cascades, including cAMP regulation, MAPK, and NF-κB pathways, with a demonstrated role in neutrophil effector functions and inflammatory responses. The receptor's expression is upregulated in inflamed and cancerous tissues and is implicated in disease contexts such as inflammation, cancer, kidney injury, and immune cell development. Beclomethasone and endogenous glucocorticoids are known agonists, with structural studies confirming direct ligand binding and activation of downstream Go protein signaling.
Ligand (glucocorticoid) binding induces conformational change and activates G protein signaling (primarily Go, but also can couple to Gi and Gs) Decreases cAMP via Gi coupling after mutation/activation Activates mitogen-activated protein kinases (MAPKs, e.g., ERK, p38) and NF-κB pathways
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adhesion G protein-coupled receptor G3 (ADGRG3).